JLJulia Latash

Julia Latash

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Julia Latash has a total of 60 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Genomic epidemiology of mpox virus during the 2022 outbreak in New York City

    by Saymon Akther, Michelle Su, Jade C. Wang, Helly Amin, Faten Taki, Nelson De La Cruz, Moinuddin Chowdhury, Tyler Clabby, Erik Kopping, Victoria E. Ruiz, et al.

    New York City (NYC) was a major hotspot during the 2022 multi-country Mpox virus (MPXV) outbreak in the U.S. To investigate the genomic characteristics of MPXV in NYC, we sequenced 1138 specimens from 758 individuals using PrimalSeq and Illumina technology and performed phylogenomic analyses alongside 2967 global MPXV sequences. Nextclade lineage assignment revealed a NYC-specific B.1.12 lineage, with phylogenetic analysis showing unique clusters in NYC and North America. MPXV lineage B-specific mutations were predominantly driven by APOBEC3 activity (53/58 mutations). APOBEC3-associated mutations were significantly higher in 2022 outbreak sequences compared to those before 2022. Intra-host genome diversity was investigated in individuals with multiple specimens (n = 360). This analysis showed that 6.4% of these individuals had distinct genomic profiles, with 4.2% likely due to co-infections with distinct MPXV strains. This study identified unique MPXV genomic profiles in NYC, estimated concurrent infections with multiple MPXV strains and emphasized the need for enhanced surveillance and public health strategies to address co-infections, especially through collaboration with labs, clinics, and community groups.


  • Open Access

    Applying prospective tree-temporal scan statistics to genomic surveillance data to detect emerging SARS-CoV-2 variants and salmonellosis clusters in New York City

    by Sharon K Greene, Julia Latash, Eric R Peterson, Alison Levin-Rector, Elizabeth Luoma, Jade C Wang, Kevin Bernard, Aaron Olsen, Lan Li, HaeNa Waechter, et al.

    Background: The detection of communicable disease clusters in genomic surveillance data typically involves the application of rule-based signaling criteria, which can be arbitrary. In contrast, scan statistics that are used for spatiotemporal cluster detection can flexibly scan in calendar time, and scan statistics that are used for pharmacovigilance can flexibly scan along hierarchical tree structures that are based on diagnosis codes. Methods: New York City (NYC) Health Department staff applied tree-temporal scan statistics prospectively to genomic surveillance data with a hierarchical nomenclature for COVID-19 and salmonellosis cases that were diagnosed among NYC residents. We searched weekly for recent case increases at any granularity, from large phylogenetic branches to small groups of indistinguishable isolates. Using free and open-source TreeScan software, we looked for emerging SARS-CoV-2 variants based on Pango lineages during August 2021–November 2023 and emerging clusters of Salmonella isolates based on allele codes during November 2022–November 2023. Results: The SARS-CoV-2 Omicron subvariant EG.5.1 first signaled as locally emerging on 22 June 2023, 7 weeks before the World Health Organization designated it as a variant of interest. During 1 year of salmonellosis analyses, TreeScan detected 15 credible clusters that were worth investigating for common exposures and two data-quality issues for correction. Conclusion: A challenge was the maintenance of timely and specific lineage assignments, and a limitation was that genetic distances between tree nodes were not considered. By automatically sifting through genomic data and generating ranked shortlists of nodes with statistically unusual recent case increases, TreeScan assisted in detecting emerging variants and clusters of communicable diseases and in prioritizing them for investigation.


  • Open Access

    Applying Prospective Tree-Temporal Scan Statistics to Genomic Surveillance Data to Detect Emerging SARS-CoV-2 Variants and Salmonellosis Clusters in New York City

    by Sharon K. Greene, Julia Latash, Eric R. Peterson, Alison Levin-Rector, Elizabeth Luoma, Jade C. Wang, Kevin Bernard, Aaron Olsen, Lan Li, HaeNa Waechter, et al.

    Genomic surveillance data are used to detect communicable disease clusters, typically by applying rule-based signaling criteria, which can be arbitrary. We applied the prospective tree-temporal scan statistic (TreeScan) to genomic data with a hierarchical nomenclature to search for recent case increases at any granularity, from large phylogenetic branches to small groups of indistinguishable isolates. Using COVID-19 and salmonellosis cases diagnosed among New York City (NYC) residents and reported to the NYC Health Department, we conducted weekly analyses to detect emerging SARS-CoV-2 variants based on Pango lineages and clusters of Salmonella isolates based on allele codes. The SARS-CoV-2 Omicron subvariant EG.5.1 first signaled as locally emerging on June 22, 2023, seven weeks before the World Health Organization designated it as a variant of interest. During one year of salmonellosis analyses, TreeScan detected fifteen credible clusters worth investigating for common exposures and two data quality issues for correction. A challenge was maintaining timely and specific lineage assignments, and a limitation was that genetic distances between tree nodes were not considered. By automatically sifting through genomic data and generating ranked shortlists of nodes with statistically unusual recent case increases, TreeScan assisted in detecting emerging communicable disease clusters and in prioritizing them for investigation.


  • Open Access

    Genomic Epidemiology of Monkeypox Virus During the 2022 Outbreak in New York City

    by Saymon Akther, Michelle Su, Jade C. Wang, Helly Amin, Faten Taki, Nelson De La Cruz, Moinuddin Chowdhury, Tyler Clabby, Erik Kopping, Victoria E. Ruiz, et al.

    New York City (NYC) was one of the hotspots of monkeypox virus (MPXV) infections in the United States during the multi-country mpox outbreak in 2022. This study used the most comprehensive dataset to date to investigate the genomic characteristics of MPXV in NYC. We performed Nextclade lineage assignment, phylogenetic and mutational analyses on 1,138 specimens from 748 individuals at the NYC Public Health Lab in the context of 2,968 MPXV sequences sampled globally. Nextclade lineage assignment showed B.1.12 as a NYC specific lineage and phylogenetic analysis showed NYC and North America specific clades. The majority of mutations showed signatures of APOBEC3 activity. When looking at the intra-host genomic diversity for MPXV, distinct MPXV genomic profiles were observed in 6.4% of individuals with multiple sampled specimens, with at least 4.2% of NYC cases due to multiple MPXV infections from distinct viral strains. Further, 13% of the sequences in infected patients had a lack of concordance between epidemiologic and genetic linkages. This study identified NYC-specific MPXV genomic profiles and provided a conservative estimate of simultaneous infections with multiple MPXV variants, likely due to behavioral risk factors during the peak of the outbreak in July 2022. Improving concordance between genomic and epidemiological clusters for mpox investigations may require expanding partnerships with testing labs, clinics, and community groups to enhance the representativeness of MPXV samples that are available for sequencing.


  • JYNNEOS™ effectiveness as post-exposure prophylaxis against mpox: Challenges using real-world outbreak data

    by Jennifer B. Rosen, Robert J. Arciuolo, Preeti Pathela, Christopher B. Boyer, Jennifer Baumgartner, Julia Latash, Lenka Malec, Ellen H. Lee, Vasudha Reddy, Renee King, et al.